Articles tagged with Mitochondrial Fission
Scientists from the University of Osaka have identified a previously unknown molecular mechanism linking mitochondrial morphology to innate immune activation. Abnormally long mitochondria can trigger the release of mitochondrial RNA into the cytosol, activating RNA-sensing proteins and leading to anti-tumor immunity.
Researchers discover GFAP's crucial role in regulating mitochondrial fusion and fission, a dynamic process that meets cells' energy needs. The study sheds light on Alexander disease, a genetic disorder caused by GFAP mutations, providing potential new avenues for therapies.
The 17th World Congress on Targeting Mitochondria will gather world's leading experts from biotechnology, pharma and academia to discuss health, longevity and precision medicine. Over 150 academic and institutional partners and 30 industrial and investment organizations are participating.
Researchers have discovered a potential treatment for traumatic brain injury (TBI) that prevents chronic neurodegeneration by targeting mitochondrial fission. P110, a small peptide agent, has been shown to halt the process and protect the brain from damage.
A study found that regular exercise increases mitochondrial fusion, benefiting muscle cells and maintaining physical fitness even in old age. Daily sessions of exercise throughout life delay the accumulation of dysfunctional mitochondria and decline in physical fitness.
ATAD3A is crucial for the movement of genetic material inside mitochondria, affecting energy production. The correct distribution of mtDNA nucleoids activates expression of respiratory chain complexes.
Scientists have identified a new pathway for peroxisome division, independent of Mitochondrial Fission Factor (MFF). The study, led by Professor Michael Schrader, reveals that PEX11β and FIS1 cooperate to divide peroxisomes, restoring normal morphology. This discovery offers potential therapeutic options for diseases caused by defects ...
Researchers from Osaka University discovered that MondoA protein delays cellular senescence by activating autophagy, promoting longevity. Activation of MondoA also maintains mitochondrial stability, preventing senescence in tissues like the kidney.
Researchers at the University of Illinois Chicago found a promising treatment for neurodegenerative diseases by stopping nerve cell degeneration. A peptide has been identified that inhibits mitochondrial fission and lets nerve cells grow normally.
Researchers at Waseda University discovered a new protein isoform called Senp5S, which helps regulate Drp1 and mitochondrial dynamics during brain development. The study suggests a novel and vital role for post-translational SUMOylation in neuronal differentiation.
Researchers investigated mitochondrial fission and discovered two types of division: midzone and peripheral. Midzone divisions have textbook machinery, while peripheral divisions are associated with stress and dysfunction. The study sheds light on regulation mechanisms and potential therapeutic targets for human diseases.
Salk researchers developed a new imaging technique to study actin's function in mitochondrial division, revealing its accumulation at fission sites. The findings provide insights into mitochondrial dysfunction linked to cancer, aging, and neurodegenerative diseases.
Researchers at Georgia State University are studying the role of an enzyme in causing diabetic vascular diseases and exploring its potential as a new treatment. The study aims to understand the molecular mechanisms behind the disease and identify a strategy to protect against its development.
Researchers have discovered that inhibiting a particular mitochondrial fission protein could reverse Parkinson's Disease symptoms by reducing cell death and dopamine release deficits. This study offers exciting potential for an effective treatment and paves the way for future studies in this field.